Published in Ann Oncol on September 01, 2012
ADG116 in Patients With Advanced/Metastatic Solid Tumors | NCT04501276
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma. Ann N Y Acad Sci (2013) 2.03
Risk of a second primary cancer after non-melanoma skin cancer in white men and women: a prospective cohort study. PLoS Med (2013) 1.06
Autophagy facilitates TLR4- and TLR3-triggered migration and invasion of lung cancer cells through the promotion of TRAF6 ubiquitination. Autophagy (2013) 1.04
T-cell and natural killer cell therapies for hematologic malignancies after hematopoietic stem cell transplantation: enhancing the graft-versus-leukemia effect. Haematologica (2015) 1.02
API5 confers tumoral immune escape through FGF2-dependent cell survival pathway. Cancer Res (2014) 1.00
Inflammation and the two-hit hypothesis of schizophrenia. Neurosci Biobehav Rev (2013) 0.98
Immune-dependent antineoplastic effects of cisplatin plus pyridoxine in non-small-cell lung cancer. Oncogene (2014) 0.97
Human cell-based artificial antigen-presenting cells for cancer immunotherapy. Immunol Rev (2014) 0.93
Impact of brief exercise on peripheral blood NK cell gene and microRNA expression in young adults. J Appl Physiol (1985) (2013) 0.91
Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells. Nanomedicine (2015) 0.91
Circulating Type-1 Anti-Tumor CD4(+) T Cells are Preferentially Pro-Apoptotic in Cancer Patients. Front Oncol (2014) 0.89
The derived neutrophil to lymphocyte ratio is an independent prognostic factor in patients with diffuse large B-cell lymphoma. Br J Cancer (2013) 0.89
Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma. Sci Rep (2016) 0.88
Prioritizing therapeutic targets using patient-derived xenograft models. Biochim Biophys Acta (2015) 0.88
Mouse hospital and co-clinical trial project--from bench to bedside. Nat Rev Clin Oncol (2015) 0.86
Mathematical model approach to describe tumour response in mice after vaccine administration and its applicability to immune-stimulatory cytokine-based strategies. AAPS J (2013) 0.85
In silico tumor control induced via alternating immunostimulating and immunosuppressive phases. Virulence (2015) 0.84
A novel prognostic factor for hepatocellular carcinoma: protein disulfide isomerase. Korean J Intern Med (2014) 0.83
Mesenchymal stem cells are enriched in head neck squamous cell carcinoma, correlates with tumour size and inhibit T-cell proliferation. Br J Cancer (2015) 0.82
Drosophila at the intersection of infection, inflammation, and cancer. Front Cell Infect Microbiol (2013) 0.82
Ion channels and anti-cancer immunity. Philos Trans R Soc Lond B Biol Sci (2014) 0.82
The Evolving Role of Immune Checkpoint Inhibitors in Cancer Treatment. Oncologist (2015) 0.81
Immunosurveillance against cancer-associated hyperploidy. Oncotarget (2012) 0.79
Inhibition of host immune response in colorectal cancer: human leukocyte antigen-G and beyond. World J Gastroenterol (2014) 0.78
T-cell immunoglobulin mucin 3 blockade drives an antitumor immune response in head and neck cancer. Mol Oncol (2016) 0.78
Anti-PD-L1 prolongs survival and triggers T cell but not humoral anti-tumor immune responses in a human MUC1-expressing preclinical ovarian cancer model. Cancer Immunol Immunother (2015) 0.78
Immune checkpoint blockade therapy for bladder cancer treatment. Investig Clin Urol (2016) 0.78
Immunotherapy for pancreatic ductal adenocarcinoma: an overview of clinical trials. Chin J Cancer Res (2015) 0.78
Animal Models of Gastrointestinal and Liver Diseases. The difficulty of animal modeling of pancreatic cancer for preclinical evaluation of therapeutics. Am J Physiol Gastrointest Liver Physiol (2015) 0.78
TroVax in colorectal cancer. Hum Vaccin Immunother (2014) 0.77
The status, limitation and improvement of adoptive cellular immunotherapy in advanced urologic malignancies. Chin J Cancer Res (2015) 0.77
Galectin-3 Binding Protein Secreted by Breast Cancer Cells Inhibits Monocyte-Derived Fibrocyte Differentiation. J Immunol (2015) 0.77
Viro-immune therapy: A new strategy for treatment of pancreatic cancer. World J Gastroenterol (2016) 0.77
Functions of Cancer-Derived Extracellular Vesicles in Immunosuppression. Arch Immunol Ther Exp (Warsz) (2017) 0.76
How to be good at being bad: centrosome amplification and mitotic propensity drive intratumoral heterogeneity. Cancer Metastasis Rev (2015) 0.76
Personalized immune-interception of cancer and the battle of two adaptive systems--when is the time right? Cancer Prev Res (Phila) (2013) 0.76
VSIG4 is highly expressed and correlated with poor prognosis of high-grade glioma patients. Am J Transl Res (2015) 0.76
Cancer cell-binding peptide fused Fc domain activates immune effector cells and blocks tumor growth. Oncotarget (2016) 0.75
Risk of malignancy in 22q11.2 deletion syndrome. Clin Case Rep (2017) 0.75
Immune-checkpoint blockade: the springboard for immuno-combination therapy. Gene Ther (2015) 0.75
Safety and Efficacy of Transplantation with Allogeneic Skin Tumors to Treat Chemically-Induced Skin Tumors in Mice. Med Sci Monit (2016) 0.75
M2 polarization of macrophages facilitates arsenic-induced cell transformation of lung epithelial cells. Oncotarget (2017) 0.75
The Physiological Role of Tumor Necrosis Factor in Human Immunity and Its Potential Implications in Spinal Manipulative Therapy: A Narrative Literature Review. J Chiropr Med (2016) 0.75
Using Murine Models to Investigate Tumor-Lymphoid Interactions: Spotlight on Chronic Lymphocytic Leukemia and Angioimmunoblastic T-Cell Lymphoma. Front Oncol (2017) 0.75
Glutamate dependent NMDA receptor 2D is a novel angiogenic tumour endothelial marker in colorectal cancer. Oncotarget (2016) 0.75
Effect of Th1/Th2 cytokine administration on proinflammatory SKOV-3 cell activation. Arch Med Sci (2015) 0.75
Repeated cycles of 5-fluorouracil chemotherapy impaired anti-tumor functions of cytotoxic T cells in a CT26 tumor-bearing mouse model. BMC Immunol (2016) 0.75
A Comparative Approach of Tumor-Associated Inflammation in Mammary Cancer between Humans and Dogs. Biomed Res Int (2016) 0.75
Distinct Blood and Visceral Adipose Tissue Regulatory T Cell and Innate Lymphocyte Profiles Characterize Obesity and Colorectal Cancer. Front Immunol (2017) 0.75
Which Metrics Are Appropriate to Describe the Value of New Cancer Therapies? Biomed Res Int (2015) 0.75
Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer. Oncologist (2016) 0.75
Comparative Gene Expression Analysis of Lymphocytes Treated with Exosomes Derived from Ovarian Cancer and Ovarian Cysts. Front Immunol (2017) 0.75
PD-1 blockade restores impaired function of ex vivo expanded CD8(+) T cells and enhances apoptosis in mismatch repair deficient EpCAM(+)PD-L1(+) cancer cells. Onco Targets Ther (2017) 0.75
Immune profiles and clinical outcomes between sepsis patients with or without active cancer requiring admission to intensive care units. PLoS One (2017) 0.75
Identification of differences in immunotherapy knowledge and practice patterns among oncologists from six European countries. Mol Clin Oncol (2014) 0.75
Chemotherapy with or without autologous cytokine-induced killer cell transfusion as the first-line treatment for stage IV gastrointestinal cancer: a phase II clinical trial. J Cancer Res Clin Oncol (2016) 0.75
Potentiation of Natural Killer Cells for Cancer Immunotherapy: A Review of Literature. Front Immunol (2017) 0.75
An immunocompetent mouse model of human glioblastoma. Oncotarget (2017) 0.75
Hallmarks of cancer: the next generation. Cell (2011) 140.01
The hallmarks of cancer. Cell (2000) 113.05
Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science (2011) 15.79
A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science (1991) 14.57
T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia. Sci Transl Med (2011) 12.58
Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol (2006) 9.42
The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research. Clin Cancer Res (2009) 6.83
Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia. N Engl J Med (2009) 5.79
Cancer immunology. N Engl J Med (2008) 5.22
Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer (2004) 4.43
Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido. Nat Med (2011) 3.12
Immune surveillance: a balance between protumor and antitumor immunity. Curr Opin Genet Dev (2008) 2.62
Features of responding T cells in cancer and chronic infection. Curr Opin Immunol (2010) 2.42
Defining the critical hurdles in cancer immunotherapy. J Transl Med (2011) 2.32
Anti-CTLA-4 antibody therapy: immune monitoring during clinical development of a novel immunotherapy. Semin Oncol (2010) 1.98
Vaccines for tumour prevention. Nat Rev Cancer (2006) 1.87
Inflammation and immune surveillance in cancer. Semin Cancer Biol (2011) 1.41
Cancer prevention by vaccination against hepatitis B. Recent Results Cancer Res (2009) 1.20